SG11202012109UA - Engineered phosphopentomutase variant enzymes - Google Patents
Engineered phosphopentomutase variant enzymesInfo
- Publication number
- SG11202012109UA SG11202012109UA SG11202012109UA SG11202012109UA SG11202012109UA SG 11202012109U A SG11202012109U A SG 11202012109UA SG 11202012109U A SG11202012109U A SG 11202012109UA SG 11202012109U A SG11202012109U A SG 11202012109UA SG 11202012109U A SG11202012109U A SG 11202012109UA
- Authority
- SG
- Singapore
- Prior art keywords
- variant enzymes
- engineered phosphopentomutase
- phosphopentomutase variant
- engineered
- enzymes
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/90—Isomerases (5.)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/52—Genes encoding for enzymes or proenzymes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/70—Vectors or expression systems specially adapted for E. coli
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/74—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/80—Vectors or expression systems specially adapted for eukaryotic hosts for fungi
- C12N15/81—Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts
- C12N15/815—Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts for yeasts other than Saccharomyces
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y504/00—Intramolecular transferases (5.4)
- C12Y504/02—Phosphotransferases (phosphomutases) (5.4.2)
- C12Y504/02007—Phosphopentomutase (5.4.2.7)
Landscapes
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Biomedical Technology (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Plant Pathology (AREA)
- Mycology (AREA)
- Medicinal Chemistry (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Enzymes And Modification Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862695491P | 2018-07-09 | 2018-07-09 | |
| PCT/US2019/040353 WO2020014046A1 (en) | 2018-07-09 | 2019-07-02 | Engineered phosphopentomutase variant enzymes |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11202012109UA true SG11202012109UA (en) | 2021-01-28 |
Family
ID=69101520
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11202012109UA SG11202012109UA (en) | 2018-07-09 | 2019-07-02 | Engineered phosphopentomutase variant enzymes |
Country Status (11)
| Country | Link |
|---|---|
| US (3) | US11034948B2 (en) |
| EP (1) | EP3821026A4 (en) |
| JP (2) | JP7493248B2 (en) |
| KR (1) | KR20210031933A (en) |
| CN (1) | CN112601821A (en) |
| AU (1) | AU2019302422B2 (en) |
| CA (1) | CA3108728A1 (en) |
| IL (1) | IL279880A (en) |
| MX (1) | MX2021000322A (en) |
| SG (1) | SG11202012109UA (en) |
| WO (1) | WO2020014046A1 (en) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA3108728A1 (en) | 2018-07-09 | 2020-01-16 | Codexis, Inc. | Engineered phosphopentomutase variant enzymes |
| CN112996511B (en) | 2018-07-09 | 2024-08-09 | 默沙东有限责任公司 | Enzymatic synthesis of 4' -ethynyl nucleoside analogues |
| CN114072165A (en) * | 2019-07-02 | 2022-02-18 | 科德克希思公司 | Engineered sucrose phosphorylase variant enzymes |
| EP4225909A1 (en) * | 2020-10-07 | 2023-08-16 | Codexis, Inc. | Engineered phosphopentomutase variant enzymes |
| WO2022133289A2 (en) * | 2020-12-18 | 2022-06-23 | Codexis, Inc. | Engineered uridine phosphorylase variant enzymes |
| CN116855471B (en) * | 2023-09-04 | 2023-11-28 | 江苏申基生物科技有限公司 | Purine nucleoside phosphorylase mutant and application thereof |
Family Cites Families (64)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6335160B1 (en) | 1995-02-17 | 2002-01-01 | Maxygen, Inc. | Methods and compositions for polypeptide engineering |
| US5605793A (en) | 1994-02-17 | 1997-02-25 | Affymax Technologies N.V. | Methods for in vitro recombination |
| US5837458A (en) | 1994-02-17 | 1998-11-17 | Maxygen, Inc. | Methods and compositions for cellular and metabolic engineering |
| US5834252A (en) | 1995-04-18 | 1998-11-10 | Glaxo Group Limited | End-complementary polymerase reaction |
| US6165793A (en) | 1996-03-25 | 2000-12-26 | Maxygen, Inc. | Methods for generating polynucleotides having desired characteristics by iterative selection and recombination |
| US20060257890A1 (en) | 1996-05-20 | 2006-11-16 | Maxygen, Inc. | Methods and compositions for cellular and metabolic engineering |
| US6395547B1 (en) | 1994-02-17 | 2002-05-28 | Maxygen, Inc. | Methods for generating polynucleotides having desired characteristics by iterative selection and recombination |
| US6995017B1 (en) | 1994-02-17 | 2006-02-07 | Maxygen, Inc. | Methods for generating polynucleotides having desired characteristics by iterative selection and recombination |
| US5928905A (en) | 1995-04-18 | 1999-07-27 | Glaxo Group Limited | End-complementary polymerase reaction |
| US6117679A (en) | 1994-02-17 | 2000-09-12 | Maxygen, Inc. | Methods for generating polynucleotides having desired characteristics by iterative selection and recombination |
| US6309883B1 (en) | 1994-02-17 | 2001-10-30 | Maxygen, Inc. | Methods and compositions for cellular and metabolic engineering |
| US6406855B1 (en) | 1994-02-17 | 2002-06-18 | Maxygen, Inc. | Methods and compositions for polypeptide engineering |
| ATE206460T1 (en) | 1994-06-03 | 2001-10-15 | Novo Nordisk Biotech Inc | PURIFIED MYCELIOPTHHORA LACCASES AND NUCLEIC ACIDS CODING THEREOF |
| WO1996000787A1 (en) | 1994-06-30 | 1996-01-11 | Novo Nordisk Biotech, Inc. | Non-toxic, non-toxigenic, non-pathogenic fusarium expression system and promoters and terminators for use therein |
| FI104465B (en) | 1995-06-14 | 2000-02-15 | Valio Oy | Protein hydrolyzates for the treatment and prevention of allergies and their preparation and use |
| US6506602B1 (en) | 1996-03-25 | 2003-01-14 | Maxygen, Inc. | Methods for generating polynucleotides having desired characteristics by iterative selection and recombination |
| US6096548A (en) | 1996-03-25 | 2000-08-01 | Maxygen, Inc. | Method for directing evolution of a virus |
| US7148054B2 (en) | 1997-01-17 | 2006-12-12 | Maxygen, Inc. | Evolution of whole cells and organisms by recursive sequence recombination |
| DK1717322T3 (en) | 1997-01-17 | 2012-10-22 | Codexis Mayflower Holdings Llc | Development of whole cells and organisms by recursive sequence recombination |
| AU6029998A (en) | 1997-01-17 | 1998-08-07 | Regents Of The University Of Minnesota | Dna molecules and protein displaying improved triazine compound degrading ability |
| US6326204B1 (en) | 1997-01-17 | 2001-12-04 | Maxygen, Inc. | Evolution of whole cells and organisms by recursive sequence recombination |
| DK1036198T3 (en) | 1997-12-08 | 2013-01-02 | California Inst Of Techn | Method for Preparation of Polynucleotide and Polypeptide Sequences |
| JP2002510506A (en) | 1998-04-02 | 2002-04-09 | テラス ジェネティック リソーシズ，インコーポレイティド | Method for obtaining plant having genetic disorder in gene sequence |
| BR9910174A (en) | 1998-05-01 | 2001-03-06 | Maxygen Inc | Process for obtaining an optimized recombinant gene for pest resistance, library, and process for obtaining an organism that is pathogenic to a vegetable pest |
| US6337186B1 (en) | 1998-06-17 | 2002-01-08 | Maxygen, Inc. | Method for producing polynucleotides with desired properties |
| US6365408B1 (en) | 1998-06-19 | 2002-04-02 | Maxygen, Inc. | Methods of evolving a polynucleotides by mutagenesis and recombination |
| EP1104459A1 (en) | 1998-08-12 | 2001-06-06 | Maxygen, Inc. | Dna shuffling of monooxygenase genes for production of industrial chemicals |
| JP2002526107A (en) | 1998-10-07 | 2002-08-20 | マキシジェン， インコーポレイテッド | DNA shuffling to generate nucleic acids for mycotoxin detoxification |
| WO2000028018A1 (en) | 1998-11-10 | 2000-05-18 | Maxygen, Inc. | Modified adp-glucose pyrophosphorylase for improvement and optimization of plant phenotypes |
| JP4221100B2 (en) | 1999-01-13 | 2009-02-12 | エルピーダメモリ株式会社 | Semiconductor device |
| US6368861B1 (en) | 1999-01-19 | 2002-04-09 | Maxygen, Inc. | Oligonucleotide mediated nucleic acid recombination |
| US6376246B1 (en) | 1999-02-05 | 2002-04-23 | Maxygen, Inc. | Oligonucleotide mediated nucleic acid recombination |
| US6436675B1 (en) | 1999-09-28 | 2002-08-20 | Maxygen, Inc. | Use of codon-varied oligonucleotide synthesis for synthetic shuffling |
| US6917882B2 (en) | 1999-01-19 | 2005-07-12 | Maxygen, Inc. | Methods for making character strings, polynucleotides and polypeptides having desired characteristics |
| EP1062614A1 (en) | 1999-01-19 | 2000-12-27 | Maxygen, Inc. | Methods for making character strings, polynucleotides and polypeptides |
| US7873477B1 (en) | 2001-08-21 | 2011-01-18 | Codexis Mayflower Holdings, Llc | Method and system using systematically varied data libraries |
| US6961664B2 (en) | 1999-01-19 | 2005-11-01 | Maxygen | Methods of populating data structures for use in evolutionary simulations |
| US8457903B1 (en) | 1999-01-19 | 2013-06-04 | Codexis Mayflower Holdings, Llc | Method and/or apparatus for determining codons |
| US7024312B1 (en) | 1999-01-19 | 2006-04-04 | Maxygen, Inc. | Methods for making character strings, polynucleotides and polypeptides having desired characteristics |
| US7702464B1 (en) | 2001-08-21 | 2010-04-20 | Maxygen, Inc. | Method and apparatus for codon determining |
| US20070065838A1 (en) | 1999-01-19 | 2007-03-22 | Maxygen, Inc. | Oligonucleotide mediated nucleic acid recombination |
| JP2003524394A (en) | 1999-02-11 | 2003-08-19 | マキシジェン， インコーポレイテッド | High-throughput mass spectrometry |
| US6365377B1 (en) | 1999-03-05 | 2002-04-02 | Maxygen, Inc. | Recombination of insertion modified nucleic acids |
| US6703240B1 (en) | 1999-04-13 | 2004-03-09 | Maxygar, Inc. | Modified starch metabolism enzymes and encoding genes for improvement and optimization of plant phenotypes |
| KR20020048930A (en) * | 1999-08-20 | 2002-06-24 | 로셰 디아그노스틱스 게엠베하 | Enzymatic synthesis of deoxyribonucleosides |
| US7430477B2 (en) | 1999-10-12 | 2008-09-30 | Maxygen, Inc. | Methods of populating data structures for use in evolutionary simulations |
| US6519065B1 (en) | 1999-11-05 | 2003-02-11 | Jds Fitel Inc. | Chromatic dispersion compensation device |
| US6686515B1 (en) | 1999-11-23 | 2004-02-03 | Maxygen, Inc. | Homologous recombination in plants |
| CA2396320A1 (en) | 2000-01-11 | 2001-07-19 | Maxygen, Inc. | Integrated systems and methods for diversity generation and screening |
| EP1272967A2 (en) | 2000-03-30 | 2003-01-08 | Maxygen, Inc. | In silico cross-over site selection |
| ATE500323T1 (en) | 2000-04-03 | 2011-03-15 | Maxygen Inc | SUBTILISIN VARIANT |
| DK1493027T3 (en) | 2002-03-01 | 2014-11-17 | Codexis Mayflower Holdings Llc | Methods, systems and software for identifying functional biomolecules |
| US7747391B2 (en) | 2002-03-01 | 2010-06-29 | Maxygen, Inc. | Methods, systems, and software for identifying functional biomolecules |
| US20050084907A1 (en) | 2002-03-01 | 2005-04-21 | Maxygen, Inc. | Methods, systems, and software for identifying functional biomolecules |
| AU2003213846A1 (en) | 2002-03-09 | 2003-09-29 | Maxygen, Inc. | Optimization of crossover points for directed evolution |
| EP1858920B1 (en) * | 2005-02-18 | 2016-02-03 | GlaxoSmithKline Biologicals SA | Proteins and nucleic acids from meningitis/sepsis-associated escherichia coli |
| US8504498B2 (en) | 2008-02-12 | 2013-08-06 | Codexis, Inc. | Method of generating an optimized, diverse population of variants |
| WO2009102901A1 (en) | 2008-02-12 | 2009-08-20 | Codexis, Inc. | Method of generating an optimized, diverse population of variants |
| US20090312196A1 (en) | 2008-06-13 | 2009-12-17 | Codexis, Inc. | Method of synthesizing polynucleotide variants |
| US8383346B2 (en) | 2008-06-13 | 2013-02-26 | Codexis, Inc. | Combined automated parallel synthesis of polynucleotide variants |
| DK3023494T3 (en) | 2008-06-13 | 2019-02-25 | Codexis Inc | PROCEDURE FOR SYNTHESIS OF POLYNUCLEOTIDE VARIETIES |
| WO2013003290A1 (en) | 2011-06-28 | 2013-01-03 | Codexis, Inc. | Protein variant generation by region shuffling |
| WO2013159055A1 (en) | 2012-04-20 | 2013-10-24 | Codexis, Inc. | Production of fatty alcohols from engineered microorganisms |
| CA3108728A1 (en) | 2018-07-09 | 2020-01-16 | Codexis, Inc. | Engineered phosphopentomutase variant enzymes |
-
2019
- 2019-07-02 CA CA3108728A patent/CA3108728A1/en active Pending
- 2019-07-02 WO PCT/US2019/040353 patent/WO2020014046A1/en active Application Filing
- 2019-07-02 CN CN201980052459.7A patent/CN112601821A/en active Pending
- 2019-07-02 MX MX2021000322A patent/MX2021000322A/en unknown
- 2019-07-02 EP EP19834475.6A patent/EP3821026A4/en active Pending
- 2019-07-02 US US16/460,062 patent/US11034948B2/en active Active
- 2019-07-02 JP JP2021500472A patent/JP7493248B2/en active Active
- 2019-07-02 SG SG11202012109UA patent/SG11202012109UA/en unknown
- 2019-07-02 KR KR1020217003849A patent/KR20210031933A/en unknown
- 2019-07-02 AU AU2019302422A patent/AU2019302422B2/en active Active
-
2020
- 2020-12-30 IL IL279880A patent/IL279880A/en unknown
-
2021
- 2021-05-10 US US17/316,165 patent/US11795445B2/en active Active
-
2023
- 2023-09-14 US US18/467,259 patent/US20240060064A1/en active Pending
-
2024
- 2024-02-13 JP JP2024019354A patent/JP2024040366A/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| CA3108728A1 (en) | 2020-01-16 |
| US20240060064A1 (en) | 2024-02-22 |
| KR20210031933A (en) | 2021-03-23 |
| US20200010823A1 (en) | 2020-01-09 |
| US11795445B2 (en) | 2023-10-24 |
| EP3821026A4 (en) | 2022-06-01 |
| JP2021530981A (en) | 2021-11-18 |
| WO2020014046A1 (en) | 2020-01-16 |
| JP2024040366A (en) | 2024-03-25 |
| US20210261940A1 (en) | 2021-08-26 |
| MX2021000322A (en) | 2021-03-25 |
| AU2019302422B2 (en) | 2022-08-04 |
| AU2019302422A1 (en) | 2021-01-07 |
| EP3821026A1 (en) | 2021-05-19 |
| IL279880A (en) | 2021-03-01 |
| JP7493248B2 (en) | 2024-05-31 |
| CN112601821A (en) | 2021-04-02 |
| US11034948B2 (en) | 2021-06-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL282092B (en) | Engineered enzymes | |
| EP4069281A4 (en) | Novel enzymes | |
| IL279880A (en) | Engineered phosphopentomutase variant enzymes | |
| IL279883A (en) | Engineered galactose oxidase variant enzymes | |
| PL3284805T3 (en) | Cleaning composition comprising enzymes | |
| IL279884A (en) | Engineered pantothenate kinase variant enzymes | |
| IL279882A (en) | Engineered deoxyribose-phosphate aldolases | |
| IL287777A (en) | Engineered t cells | |
| IL271813A (en) | Recombinant uricase enzyme | |
| EP3652203A4 (en) | Engineered tsc2 | |
| IL290978A (en) | Engineered lipase variants | |
| GB2613719B (en) | Engineered soil | |
| GB201803491D0 (en) | Novel enzymes | |
| PL3647404T3 (en) | Bioreactor | |
| GB201912198D0 (en) | Engineered CRISPRa | |
| GB201912179D0 (en) | Engineered CRISPRa | |
| GB201902262D0 (en) | Micro-organism | |
| GB201902258D0 (en) | Micro-organism | |
| GB201905619D0 (en) | Engineered soil | |
| GB201808432D0 (en) | Engineered Soil | |
| GB201903621D0 (en) | Wooltop technology | |
| GB201917265D0 (en) | Bonded neurotoxins | |
| GB201817354D0 (en) | Engineered FC | |
| GB201907249D0 (en) | Disclosure | |
| GB201906344D0 (en) | Disclosure |